Taiwan · Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 4.42 billion. The enterprise value is 3.50 billion.
| Market Cap | 4.42B |
| Enterprise Value | 3.50B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Jul 1, 2026 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has increased by 18.37% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | +18.37% |
| Shares Change (QoQ) | +87.59% |
| Owned by Insiders (%) | 25.74% |
| Owned by Institutions (%) | 1.25% |
| Float | 14.99M |
Valuation Ratios
The trailing PE ratio is 18.75.
| PE Ratio | 18.75 |
| Forward PE | n/a |
| PS Ratio | 4.03 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | 19.68 |
| P/OCF Ratio | 19.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.90, with an EV/FCF ratio of 15.59.
| EV / Earnings | 12.50 |
| EV / Sales | 3.19 |
| EV / EBITDA | 9.90 |
| EV / EBIT | 10.21 |
| EV / FCF | 15.59 |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.47 |
| Quick Ratio | 3.90 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.17 |
| Interest Coverage | 261.53 |
Financial Efficiency
Return on equity (ROE) is 19.54% and return on invested capital (ROIC) is 55.01%.
| Return on Equity (ROE) | 19.54% |
| Return on Assets (ROA) | 11.86% |
| Return on Invested Capital (ROIC) | 55.01% |
| Return on Capital Employed (ROCE) | 24.88% |
| Weighted Average Cost of Capital (WACC) | 3.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.61 |
| Inventory Turnover | 2.37 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 73.44 million in taxes.
| Income Tax | 73.44M |
| Effective Tax Rate | 20.76% |
Stock Price Statistics
The stock price has decreased by -29.61% in the last 52 weeks. The beta is -0.05, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -29.61% |
| 50-Day Moving Average | 106.11 |
| 200-Day Moving Average | 116.91 |
| Relative Strength Index (RSI) | 32.39 |
| Average Volume (20 Days) | 42,583 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.10 billion and earned 280.33 million in profits. Earnings per share was 5.24.
| Revenue | 1.10B |
| Gross Profit | 739.36M |
| Operating Income | 343.13M |
| Pretax Income | 353.77M |
| Net Income | 280.33M |
| EBITDA | 348.02M |
| EBIT | 343.13M |
| Earnings Per Share (EPS) | 5.24 |
Balance Sheet
The company has 959.17 million in cash and 38.28 million in debt, with a net cash position of 920.89 million or 20.44 per share.
| Cash & Cash Equivalents | 959.17M |
| Total Debt | 38.28M |
| Net Cash | 920.89M |
| Net Cash Per Share | 20.44 |
| Equity (Book Value) | 1.35B |
| Book Value Per Share | 15.90 |
| Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was 231.14 million and capital expenditures -6.39 million, giving a free cash flow of 224.75 million.
| Operating Cash Flow | 231.14M |
| Capital Expenditures | -6.39M |
| Depreciation & Amortization | 4.89M |
| Net Borrowing | -10.29M |
| Free Cash Flow | 224.75M |
| FCF Per Share | 4.99 |
Margins
Gross margin is 67.36%, with operating and profit margins of 31.26% and 25.54%.
| Gross Margin | 67.36% |
| Operating Margin | 31.26% |
| Pretax Margin | 32.23% |
| Profit Margin | 25.54% |
| EBITDA Margin | 31.71% |
| EBIT Margin | 31.26% |
| FCF Margin | 20.48% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 8.15%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 8.15% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 160.70% |
| Buyback Yield | -18.37% |
| Shareholder Yield | -10.22% |
| Earnings Yield | 6.34% |
| FCF Yield | 5.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Dr. Wu Skincare has an Altman Z-Score of 12.83 and a Piotroski F-Score of 4.
| Altman Z-Score | 12.83 |
| Piotroski F-Score | 4 |